Trastuzumab emtansine: Powder for I.V. infusion 100 mg, Powder for I.V. infusion 160 mg; Kadcyla® Page last updated: 6 March 2020 Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)